borderline significantp = 0.056
Likewise, we found a significant reduction in the fasting blood glucose level [from 5.8 (5.5–6.4) to 5.6 mmol/L (5.3–6.2), p = 0.02], a numeric, but non-significant, decrease in the fasting insulin levels [from 102 (62–124) to 83 (57–107), p = 0.25], and a borderline significant decrease in homeostatic model assessment of insulin resistance (HOMA-IR) [from 3.7 (2.3–4.6) to 2.8 (2.2–3.8), p = 0.056].